NONOF

NOVO NORDISK A/S B NEW by Novo-Nordisk A/S (NONOF)

About NOVO NORDISK A/S B NEW by Novo-Nordisk A/S (NONOF)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Details

Daily high
$46.96
Daily low
$45.00
Price at open
$46.75
52 Week High
$82.50
52 Week Low
$34.00
Market cap
203.9B
Dividend yield
3.92%
Volume
21,757
Avg. volume
65,133
P/E ratio
10.79

NOVO NORDISK A/S B NEW by Novo-Nordisk A/S News

Details

Daily high
$46.96
Daily low
$45.00
Price at open
$46.75
52 Week High
$82.50
52 Week Low
$34.00
Market cap
203.9B
Dividend yield
3.92%
Volume
21,757
Avg. volume
65,133
P/E ratio
10.79